Lipocine
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Lipocine's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 670% to -$2,850,818. Profit margin reached 574%. Total operating expenses were $15,080,139.

Profit Margin

Lipocine Inc. (NASDAQ:LPCN): Profit margin
2014 0 -20.37M
2015 0 -18.20M
2016 0 -18.97M
2017 0 -20.98M
2018 428.03K -11.66M -2724.11%
2019 164.99K -13.00M -7883.72%
2020 0 -20.96M
2021 16.14M -634.39K -3.93%
2022 500K -10.75M -2151.73%
2023 -2.85M -16.35M 573.59%

LPCN Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
-2.85M500K16.14M0164.99K428.03K0000
Cost of revenue
08.55M7.66M07.46M6.46M08.07M00
Gross profit
-2.85M-8.05M8.47M0-7.30M-6.03M0-8.07M00
Operating exp.
Research and development
10.17M8.55M7.66B9.74M7.46M6.46M11.00M8.07M12.58M15.47M
Selling and marketing
0000000000
Total operating expenses
15.08M4.06M5.32M20.65M5.59M5.28M20.98M10.38M18.38M20.48M
Operating income
-17.93M-12.11M3.14M-17.99M-12.90M-11.32M-21.21M-19.18M-18.38M-20.48M
Other income (expenses), net
1.57M1.36M-3.77M-2.96M-106.85K-333.50K235.81K-512.55K173.89K108.33K
Income before tax
-16.35M-10.75M-634.19K-20.96M-13.00M-11.65M-20.98M-18.97M-18.20M-20.37M
Income tax expense
755681200200200700700752200200
Net income
-16.35M-10.75M-634.39K-20.96M-13.00M-11.66M-20.98M-18.97M-18.20M-20.37M
Earnings per share
Basic EPS
-3.14-2.07-0.12-6.46-8.54-9.35-17.79-17.66-18.79-27.13
Diluted EPS
-3.14-2.07-0.12-6.4-8.54-9.28-17.85-17.66-18.87-27.2
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source